Table 1.
Clinicopathological features of ovarian cancer patients
| High expression (n = 30) | Low expression (n = 53) | P‐value | |
|---|---|---|---|
| Age (mean ± SD) | 55.1 ± 10.6 | 55.5 ± 15.2 | 0.5538 |
| Menstruation | |||
| Premenopause | 13 | 16 | 0.4486 |
| Postmenopouse | 14 | 32 | |
| Unknown | 3 | 5 | |
| Clinical stage | |||
| I | 22 | 28 | 0.0536 |
| II, III, IV | 8 | 25 | |
| Lymph node metastasis | |||
| (+) | 4 | 13 | 0.1486 |
| (−) | 23 | 39 | |
| NX | 3 | 1 | |
| Histology | |||
| Serous carcinoma | 2 | 24 | 0.0005*** |
| Clear cellcarcinoma | 11 | 14 | |
| Endometrioid carcinoma | 7 | 10 | |
| Mucinous carcinoma | 10 | 5 | |
The criterion for validating high or low FBXW7 expression groups was determined as greater or less than an arbitrary value.